GANX
Gain Therapeutics Inc.
$1.74
+$0.16(+10.13%)
20
Overall
--
Value
20
Tech
--
Quality
Market Cap
$56.80M
Volume
864.47K
52W Range
$1.41 - $3.19
Target Price
$7.71
EPS Estimates Overview
| Current Quarter | $-0.15 | Next Quarter | $-0.16 |
| Current Year | $-0.68 | Next Year | $-0.73 |
| QoQ Growth | -6.7% | YoY Growth | -7.4% |
| 3Y EPS CAGR | +13.4% | Target Price | $7.71 |
| Consensus | Buy | Upside | +343.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GANX | $1.74 | +10.1% | 864.47K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |